{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:57:35Z","timestamp":1787702255463,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"\n Objectives:<\/jats:title>\n The 2012 Surviving Sepsis Campaign pediatric guidelines recommend stress dose hydrocortisone in children experiencing catecholamine-dependent septic shock with suspected or proven absolute adrenal insufficiency. We evaluated whether stress dose hydrocortisone therapy in children with catecholamine dependent septic shock correlated with random serum total cortisol levels and was associated with improved outcomes.<\/jats:p>\n <\/jats:sec>\n \n Design:<\/jats:title>\n Retrospective cohort study.<\/jats:p>\n <\/jats:sec>\n \n Setting:<\/jats:title>\n Non-cardiac PICU.<\/jats:p>\n <\/jats:sec>\n \n Patients:<\/jats:title>\n Critically ill children (1 mo to 18 yr) admitted between January 1, 2013, and December 31, 2013, with catecholamine dependent septic shock who had random serum total cortisol levels measured prior to potential stress dose hydrocortisone therapy.<\/jats:p>\n <\/jats:sec>\n \n Interventions:<\/jats:title>\n None.<\/jats:p>\n <\/jats:sec>\n \n Measurements and Main Results:<\/jats:title>\n The cohort was dichotomized to random serum total cortisol less than 18 mcg\/dL and greater than or equal to 18 mcg\/dL. Associations of stress dose hydrocortisone with outcomes: PICU mortality, PICU and hospital length of stay, ventilator-free days, and vasopressor-free days were examined. Seventy children with catecholamine-dependent septic shock and measured random serum total cortisol levels were eligible (16% PICU mortality). Although 43% (30\/70) had random serum total cortisol less than 18 \u03bcg\/dL, 60% (42\/70) received stress dose hydrocortisone. Children with random serum total cortisol less than 18 \u03bcg\/dL had lower severity of illness and lower Vasopressor Inotrope Scores than those with random serum total cortisol greater than or equal to 18 \u03bcg\/dL (all p<\/jats:italic> < 0.05). Children with stress dose hydrocortisone had higher severity of illness and PICU mortality than those without stress dose hydrocortisone (all p<\/jats:italic> < 0.05). Mean random serum total cortisol levels were similar in children with and without stress dose hydrocortisone (21.1 vs 18.7 \u03bcg\/dL; p<\/jats:italic> = 0.69). In children with random serum total cortisol less than 18 \u03bcg\/dL, stress dose hydrocortisone was associated with greater PICU and hospital length of stay and fewer ventilator-free days (all p<\/jats:italic> < 0.05). In children with random serum total cortisol greater than 18 \u03bcg\/dL, stress dose hydrocortisone was associated with greater PICU mortality and fewer ventilator-free days and vasopressor-free days (all p<\/jats:italic> < 0.05).<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Stress dose hydrocortisone therapy in children with catecholamine-dependent septic shock correlated more with severity of illness than random serum total cortisol levels and was associated with worse outcomes, irrespective of random serum total cortisol levels.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001237","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T14:58:46Z","timestamp":1498661926000},"page":"e406-e414","source":"Crossref","is-referenced-by-count":29,"title":["Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes*"],"prefix":"10.1097","volume":"18","author":[{"given":"Blake","family":"Nichols","sequence":"first","affiliation":[{"name":"Division of Pediatric Critical Care, Children\u2019s Medical Center, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri","family":"Kubis","sequence":"additional","affiliation":[{"name":"Department of Nursing, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hewlett","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadir","family":"Yehya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/PCC.0000000000000254","article-title":"Pediatric severe sepsis: Current trends and outcomes from the Pediatric Health Information Systems database.","volume":"15","author":"Ruth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/PCC.0000000000000225","article-title":"Pediatric severe sepsis in U.S. children\u2019s hospitals.","volume":"15","author":"Balamuth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/PCC.0b013e3182a551c8","article-title":"Functional outcomes in pediatric severe sepsis: Further analysis of the researching severe sepsis and organ dysfunction in children: A global perspective trial.","volume":"14","author":"Farris","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/CCM.0b013e31820eb4e4","article-title":"Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor-dependent shock.","volume":"39","author":"Hebbar","year":"2011","journal-title":"Crit Care Med"},{"key":"R7-20230823","first-page":"265","article-title":"Corticosteroid\/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli.","volume":"16","author":"Hinshaw","year":"1985","journal-title":"Circ Shock"},{"key":"R8-20230823","first-page":"55","article-title":"Glucocorticoid and antibiotic effects on hepatic microcirculation and associated host responses in lethal Gram-negative bacteremia.","volume":"40","author":"Balis","year":"1979","journal-title":"Lab Invest"},{"key":"R9-20230823","first-page":"183","article-title":"The benefits of corticosteroid given after the onset of hypotension during endotoxin shock in the conscious rat.","volume":"10","author":"Schaefer","year":"1983","journal-title":"Adv Shock Res"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-20230823","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis.","volume":"12","author":"Annane","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.PCC.0000160596.31238.72","article-title":"A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: What is the role of steroids?","volume":"6","author":"Markovitz","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PCC.0b013e3181d903f6","article-title":"Adjunctive corticosteroid therapy in pediatric severe sepsis: Observations from the RESOLVE study.","volume":"12","author":"Zimmerman","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PCC.0b013e31828a8125","article-title":"A systematic review and meta-analysis on the effect of steroids in pediatric shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/PEC.0000000000000561","article-title":"A survey of attitudes and practices regarding the use of steroid supplementation in pediatric sepsis.","volume":"31","author":"Carmean","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PCC.0b013e31828a7287","article-title":"A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and\/or vasoactive infusion-dependent shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2110-5820-3-7","article-title":"Management of children with sepsis and septic shock: A survey among pediatric intensivists of the R\u00e9seau M\u00e8re-Enfant de la Francophonie.","volume":"3","author":"Santschi","year":"2013","journal-title":"Ann Intensive Care"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive-Inotropic Score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated Pediatric Risk of Mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.110.3.563","article-title":"Assessment of adrenal function in the initial phase of meningococcal disease.","volume":"110","author":"Bone","year":"2002","journal-title":"Pediatrics"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00006454-200204000-00013","article-title":"Low serum cortisol in combination with high adrenocorticotrophic hormone concentrations are associated with poor outcome in children with severe meningococcal disease.","volume":"21","author":"De Kleijn","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/00003246-199910000-00032","article-title":"Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency?","volume":"27","author":"Riordan","year":"1999","journal-title":"Crit Care Med"},{"key":"R25-20230823","first-page":"1238","article-title":"Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone.","volume":"80","author":"Vermes","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.200911-1738OC","article-title":"A prospective multicenter study of adrenal function in critically ill children.","volume":"182","author":"Menon","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00134-007-0699-7","article-title":"Adrenal response in children with septic shock.","volume":"33","author":"Casartelli","year":"2007","journal-title":"Intensive Care Med"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jpeds.2016.05.020","article-title":"Cortisol correlates with severity of illness and poorly reflects adrenal function in Pediatric Acute Respiratory Distress Syndrome.","volume":"177","author":"Yehya","year":"2016","journal-title":"J Pediatr"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness.","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S2213-8587(15)00224-7","article-title":"New insights into the controversy of adrenal function during critical illness.","volume":"3","author":"Boonen","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2014-2429","article-title":"Impact of duration of critical illness on the adrenal glands of human intensive care patients.","volume":"99","author":"Boonen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.resuscitation.2015.01.007","article-title":"Sodium bicarbonate use during in-hospital pediatric pulseless cardiac arrest - a report from the American Heart Association Get With The Guidelines(\u00ae)-Resuscitation.","volume":"89","author":"Raymond","year":"2015","journal-title":"Resuscitation"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1542\/peds.2007-1555","article-title":"Calcium use during in-hospital pediatric cardiopulmonary resuscitation: A report from the National Registry of Cardiopulmonary Resuscitation.","volume":"121","author":"Srinivasan","year":"2008","journal-title":"Pediatrics"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"e112702","DOI":"10.1371\/journal.pone.0112702","article-title":"Corticosteroids and pediatric septic shock outcomes: A risk stratified analysis.","volume":"9","author":"Atkinson","year":"2014","journal-title":"PLoS One"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SHK.0000000000000355","article-title":"A cohort study of pediatric shock: Frequency of corticosteriod use and association with clinical outcomes.","volume":"44","author":"Menon","year":"2015","journal-title":"Shock"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.PCC.0000288710.11834.E6","article-title":"A history of adjunctive glucocorticoid treatment for pediatric sepsis: Moving beyond steroid pulp fiction toward evidence-based medicine.","volume":"8","author":"Zimmerman","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/rccm.201401-0171OC","article-title":"Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.","volume":"189","author":"Wong","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock.","volume":"191","author":"Wong","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13063-016-1365-6","article-title":"Steroids in fluid and\/or vasoactive infusion dependent pediatric shock: Study protocol for a randomized controlled trial.","volume":"17","author":"O\u2019Hearn","year":"2016","journal-title":"Trials"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201709000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:15:44Z","timestamp":1692836144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201709000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001237","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}